SCNX Latest Headlines

Scienture Holdings Regains Nasdaq Compliance Amid Revenue Surge

at www.tipranks.com (Mon, 19-Oct 4:32 PM)

Scienture Posts Preliminary Q3 Revenue of About $1.22 Million as REZENOPY Launch Adds a Second Commercial Product

Market Chameleon (Tue, 13-Oct 11:23 AM)

SCNX Highlights Pediatric Hospital Formulary Additions as Arbli Targets a $219 Million Losartan Market

Market Chameleon (Fri, 2-Oct 9:51 AM)

Scienture (SCNX) Locks in Exclusive Distribution Channel for REZENOPY Across About 2,000 Opioid Treatment Program Clinics

Market Chameleon (Tue, 22-Sep 11:01 AM)

SCIENTURE’s REZENOPY Launch Expands Access to High-Dose Opioid Overdose Treatment Across the U.S.

Market Chameleon (Wed, 12-Aug 11:58 AM)